Literature DB >> 11786434

Gathering intelligence on antiplatelet drugs: the view from 30 000 feet. When combined with other information overviews lead to conviction.

Muredach Reilly, Garret A FitzGerald.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11786434      PMCID： PMC1122024          DOI： 10.1136/bmj.324.7329.59

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Platelet-active drugs : the relationships among dose, effectiveness, and side effects.

Authors:  C Patrono; B Coller; J E Dalen; G A FitzGerald; V Fuster; M Gent; J Hirsh; G Roth
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Preventing atherosclerotic events with aspirin.

Authors:  John G F Cleland
Journal:  BMJ       Date:  2002-01-12

Review 3.  The coxibs, selective inhibitors of cyclooxygenase-2.

Authors:  G A FitzGerald; C Patrono
Journal:  N Engl J Med       Date:  2001-08-09       Impact factor: 91.245

Review 4.  Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists.

Authors:  G A FitzGerald
Journal:  Am J Cardiol       Date:  1991-09-03       Impact factor: 2.778

Review 5.  Dipyridamole.

Authors:  G A FitzGerald
Journal:  N Engl J Med       Date:  1987-05-14       Impact factor: 91.245

Review 6.  Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-15

7.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

8.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

Review 9.  Aspirin: new cardiovascular uses for an old drug.

Authors:  C Patrono
Journal:  Am J Med       Date:  2001-01-08       Impact factor: 4.965

10.  Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-22
  10 in total
  3 in total

1.  Antiplatelet therapy and atherosclerotic events. Commentary is inaccurate.

Authors:  Cathie Sudlow; Peter Sandercock; Charles Warlow
Journal:  BMJ       Date:  2002-04-13

2.  Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition.

Authors:  Ying Yu; Yan Cheng; Jinjin Fan; Xin-Sheng Chen; Andres Klein-Szanto; Garret A Fitzgerald; Colin D Funk
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

3.  Acute coronary disease Athero-Inflammation: Therapeutic approach.

Authors:  Raul Altman
Journal:  Thromb J       Date:  2003-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.